Matthew A Davis Selected Research

Matthew A Davis Research Topics

Disease

7	Atherosclerosis 11/2015 - 04/2008
4	Inflammation (Inflammations) 01/2020 - 09/2008
4	Hypercholesterolemia 11/2015 - 04/2008
3	Insulin Resistance 01/2020 - 09/2008
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2013 - 09/2008
2	Back Pain (Backache) 01/2022 - 01/2013
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2014 - 01/2014
2	Obesity 10/2013 - 09/2008
2	Hyperlipidemias (Hyperlipidemia) 06/2012 - 09/2008
2	Neoplasms (Cancer) 10/2007 - 07/2007
2	Hepatocellular Carcinoma (Hepatoma) 03/2006 - 09/2005
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022
1	Prediabetic State (Prediabetes) 01/2022
1	Chronic Disease (Chronic Diseases) 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Urinary Incontinence 05/2020
1	Diabetes Mellitus 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Hypertrophy 01/2020
1	Anxiety Disorders (Anxiety Disorder) 07/2017
1	Hepatitis 01/2017
1	Heart Failure 01/2017
1	Fetal Weight 03/2015
1	Birth Weight (Birth Weights) 03/2015
1	Non-alcoholic Fatty Liver Disease 10/2013
1	Chanarin-Dorfman Syndrome 02/2012
1	Human Influenza (Influenza) 01/2012
1	Scoliosis 10/2009
1	Hypersensitivity (Allergy) 09/2008
1	Tension-Type Headache (Tension Headache) 08/2008
1	Headache (Headaches) 08/2008
1	Gallstones (Gallstone) 02/2008
1	Pheochromocytoma 10/2007
1	Low Back Pain (Lumbago) 10/2007
1	Spasm (Spasms) 07/2007
1	Pain (Aches) 07/2007

Drug/Important Bio-Agent (IBA)

6	CholesterolIBA 01/2014 - 03/2006
4	LipidsIBA 01/2017 - 10/2009
3	Sterol O-AcyltransferaseIBA 10/2009 - 04/2008
2	Insulin (Novolin)FDA Link 01/2020 - 02/2012
2	Sterol O-Acyltransferase 2IBA 11/2015 - 10/2014
2	LDL CholesterolIBA 01/2014 - 01/2014
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2010 - 09/2008
2	Lipoproteins (Lipoprotein)IBA 10/2009 - 09/2008
2	Antisense OligonucleotidesIBA 09/2008 - 04/2008
1	insulin receptor-related receptor (IRR)IBA 01/2022
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022
1	AdiponectinIBA 01/2020
1	Opioid Analgesics (Opioids)IBA 07/2017
1	ORALIT (ORS)IBA 01/2017
1	pyripyropene AIBA 11/2015
1	1,11- O- o- methylbenzylidene- 7- O- p- cyanobenzoyl- 1,7,11- trideacetylpyripyropene AIBA 11/2015
1	poststatinIBA 11/2015
1	ArsenicIBA 03/2015
1	Cholesterol Esters (Cholesteryl Esters)IBA 10/2014
1	LDL Receptors (LDL Receptor)IBA 10/2014
1	EnzymesIBA 10/2014
1	HydrolasesIBA 10/2013
1	Serine (L-Serine)FDA Link 10/2013
1	Dietary CholesterolIBA 06/2012
1	Triglycerides (Triacylglycerol)IBA 02/2012
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2012
1	Fish OilsIBA 01/2010
1	Stearoyl-CoA DesaturaseIBA 01/2010
1	Estrogens (Estrogen)FDA Link 10/2009
1	Oleic Acid (Oleate)IBA 09/2008
1	Membrane LipidsIBA 09/2008
1	Toll-Like Receptor 4IBA 09/2008
1	stearoyl-coenzyme A (stearoyl-CoA)IBA 09/2008
1	Apolipoprotein B-100 (Apo B 100)IBA 09/2008
1	salicylhydroxamic acid (SHAM)IBA 08/2008
1	Bile Acids and Salts (Bile Acids)IBA 02/2008
1	Liver X ReceptorsIBA 02/2008
1	Messenger RNA (mRNA)IBA 02/2008
1	CatecholaminesIBA 10/2007
1	ElementsIBA 09/2005
1	Hepatocyte Nuclear Factor 1IBA 09/2005

Therapy/Procedure

2	Activities of Daily Living (ADL) 05/2020 - 01/2017
2	Therapeutics 10/2013 - 01/2010
2	Complementary Therapies (Alternative Medicine) 01/2013 - 01/2012
1	Conservative Treatment 01/2022
1	Ambulatory Care (Outpatient Care) 01/2021
1	Glycemic Control 01/2020
1	Spinal Fusion (Spondylosyndesis) 10/2009
1	Massage (Zone Therapy) 07/2007
1	Radiotherapy 07/2007
1	Spinal Manipulation 07/2007
1	Contraindications 07/2007
1	Palliative Care (Palliative Therapy) 07/2007